Doctor Educationis / Ototoxic induced hearing loss is a common adverse event related to aminoglycosides used in Multi Drug Resistant -Tuberculosis treatment. Exposure to ototoxic drugs damages the structures of the inner ear. Symptomatic hearing loss presents as tinnitus, decreased hearing, a blocked sensation, difficulty understanding speech, and perception of fluctuating hearing, dizziness and hyperacusis/recruitment. The World Health Organization (1995) indicated that most cases of ototoxic hearing loss globally could be attributed to treatment with aminoglycosides. The aim of the study was to determine the proportion of DR-TB patients initiated on treatment at three decentralized sites during a defined period (1st October to 31st December 2015) who developed ototoxic induced hearing loss and the corresponding risk factors, whilst receiving audiological monitoring with an extended high frequency audiometer (KUDUwave). A retrospective cross-sectional study was conducted. Cumulatively across the three decentralized sites, 69 patient records were reviewed that met the inclusion criteria of the study. The mean age of the patients was 36.1, with a standard deviation (SD) of 10.7 years; more than half (37) were female. Ototoxicity , a threshold shift, placing patients at risk of developing a hearing loss was detected in 56.5% (n=39)of patients and not detected in 30.4%(n=21).The remaining 13,1% (n=9)is missing data. As a result, the regimen was adjusted in 36.2% of patients. . From the 53 patients who were tested for hearing loss post completion of the injectable phase of treatment, 22.6% (n=12) had normal hearing, 17.0 % (n=9) had unilateral hearing loss, and 60.4% (n=32) had bilateral hearing loss. Therefore, a total of 41 patients had a degree of hearing loss: over 30% (n=22)had mild to moderate hearing loss, and only about 15% (n=11)had severe to profound hearing loss. Analysis of risk factors showed that having ototoxicity detected and not adjusting regimen significantly increases the risk of patients developing a hearing loss. The key findings of the study have shown that a significant proportion of DR-TB patients receiving an aminoglycoside based regimen are at risk of developing ototoxic induced hearing loss, despite receiving audiological monitoring with an extended high frequency audiometer that allows for early detection of ototoxicity (threshold shift).

The primary aim of the research was to describe hearing function in a group of children with chronic renal dysfunction receiving treatment in an academic hospital in Johannesburg, South Africa. Specific objectives in the study were to determine the prevalence of hearing loss in paediatric patients with chronic renal dysfunction; to describe the type, degree and configuration of the hearing loss; and to establish if there was a relationship between the presenting hearing loss and the severity of renal dysfunction, the different treatment regimens, duration of renal dysfunction, and the duration of treatment. One hundred children between the ages five -18 years participated in the study and comprised 65 males and 35 females. The mean age of the participants was 11.68 years. A cross-sectional, descriptive, quantitative research design was employed. All participants underwent a case history interview and a full audiological examination which included an otoscopic examination, immittance testing (tympanometry and ipsilateral acoustic reflex testing), pure tone audiometry including extended high frequency testing up to 16 kilohertz as well as diagnostic distortion product otoacoustic emission testing. A record review was also done. Both descriptive and inferential statistics were used to analyse the collected data. Inferential statistics included parametric measures using multiple regression measures as well as non parametric measures using the Kruskal-Wallis statistical analysis. Results revealed that there was a high prevalence of hearing loss in children with chronic renal dysfunction. Results from the extended high frequency pure tone testing as well as the diagnostic distortion product testing revealed that the most common hearing loss was a low and high to ultrahigh frequency mild sensorineural hearing loss. The study showed that there was no relationship between the severity of hearing loss and the severity of renal dysfunction, or the duration of renal dysfunction and the duration of treatment. However, the study showed that there was a relationship between the severity of hearing loss and certain treatments, that is, v haemodialysis and the use of ototoxic medication such as loop diuretics, tuberculosis medication, and antimalarial medication. As the potential to miss hearing loss in this population is high, the research highlighted the importance of extended high frequency audiometry as well as diagnostic distortion product otoacoustic emission testing for the use of ototoxic monitoring in patients with chronic renal dysfunction. The research also highlighted the need for further research in this area as well as the need for educating medical personnel and caregivers working with children with chronic renal disease.

BACKGROUND: The aim of this study was to evaluate distortion product otoacoustic emissions (DPOAEs) and extended high-frequency (EHF) thresholds in a control group and in patients with normal hearing sensitivity in the conventional frequency range and reporting unilateral tinnitus. MATERIAL/METHODS: Seventy patients were enrolled in the study: 47 patients with tinnitus in the left ear (Group 1) and 23 patients with tinnitus in the right ear (Group 2). The control group included 60 otologically normal subjects with no history of pathological tinnitus. Pure-tone thresholds were measured at all standard frequencies from 0.25 to 8 kHz, and at 10, 12.5, 14, and 16 kHz. The DPOAEs were measured in the frequency range from approximately 0.5 to 9 kHz using the primary tones presented at 65/55 dB SPL. RESULTS: The left ears of patients in Group 1 had higher median hearing thresholds than those in the control subjects at all 4 EHFs, and lower mean DPOAE levels than those in the controls for almost all primary frequencies, but significantly lower only in the 2-kHz region. Median hearing thresholds in the right ears of patients in Group 2 were higher than those in the right ears of the control subjects in the EHF range at 12.5, 14, and 16 kHz. The mean DPOAE levels in the right ears were lower in patients from Group 2 than those in the controls for the majority of primary frequencies, but only reached statistical significance in the 8-kHz region. CONCLUSIONS: Hearing thresholds in tinnitus ears with normal hearing sensitivity in the conventional range were higher in the EHF region than those in non-tinnitus control subjects, implying that cochlear damage in the basal region may result in the perception of tinnitus. In general, DPOAE levels in tinnitus ears were lower than those in ears of non-tinnitus subjects, suggesting that subclinical cochlear impairment in limited areas, which can be revealed by DPOAEs but not by conventional audiometry, may exist in tinnitus ears. For patients with tinnitus, DPOAE measures combined with behavioral EHF hearing thresholds may provide additional clinical information about the status of the peripheral hearing.

No description available.

Abstract This research on military aviation noise was conducted because the personnel working with military aircraft were concerned about noise induced hearing damage. In addition, comprehensive data on hearing impairments and occupational exposure of military pilots in the Finnish Air Force was not available. Moreover, data on the effects of overflight noise of military jets was necessary for the evaluation of noise induced hearing deteriorations of members of the public who might be exposured accidentally for the low-level jets' overflights. The averaged noise exposure levels of pilots varied during a flight from 97 dB(A) to 106 dB(A) in the cockpit and from 83 dB(A) to 100 dB(A) at the entrance of the ear canal. Radio noise was 4–10 dB higher than background noise inside the helmet. The attenuation provided by air crew helmets varied from10 to 21 dB(A) in the laboratory, and was at the same level during real flights. The attenuation measured in the laboratory and in working conditions was about 30 dB(A) for earmuffs. An active noise cancellation (ANC) device decreased averaged noise exposure (LAeq8min) 4–8 dB over the noise attenuation of the same helmets when the ANC system was off. The noise of overflights by military jets were measured and the noise levels were lower than those known to cause the permanent threshold shifts. However, noise induced hearing damages might be possible in certain conditions. In order to assess the hearing loss risk of pilots, hearing thresholds were measured before and after one flight using both conventional and extended high frequency (EHF) audiometry. Minor temporary threshold shifts (TTS) were revealed. The risk of noise-induced damage at the studied exposure levels is, in all probability, rather small. A novel NoiseScan data management system proved to be an interesting tool in assessment of the risk of developing hearing impairment on the basis of known risk factors. Due to the small number of risk factors, the hearing of pilots was shown to be at considerably less risk than that of industrial workers in Finland.